FLGT

FLGT

USD

Fulgent Genetics Inc. Common Stock

$22.880-0.060 (-0.262%)

Echtzeitkurs

Healthcare
Diagnostics & Research
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$22.940

Hoch

$23.100

Tief

$22.631

Volumen

0.01M

Unternehmensfundamentaldaten

Marktkapitalisierung

700.3M

Branche

Diagnostics & Research

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

0.22M

Börse

NGM

Währung

USD

52-Wochen-Spanne

Tief $14.57Aktuell $22.880Hoch $24.64

Ähnliche Nachrichten

Analyst Upgrades

UBS Upgrades Fulgent Genetics to Buy, Raises Price Target to $30

UBS analyst Lu Li upgrades Fulgent Genetics from Neutral to Buy and raises the price target from $20 to $30.

Mehr anzeigen
UBS Upgrades Fulgent Genetics to Buy, Raises Price Target to $30
Analyst Upgrades

Piper Sandler Maintains Neutral on Fulgent Genetics, Lowers Price Target to $21

Piper Sandler analyst David Westenberg maintains Fulgent Genetics with a Neutral and lowers the price target from $23 to $21.

Mehr anzeigen
Piper Sandler Maintains Neutral on Fulgent Genetics, Lowers Price Target to $21
Earnings Call Transcripts

Fulgent Genetics, Inc. (FLGT) Q2 2025 Earnings Call Transcript

Fulgent Genetics, Inc. (FLGT) Q2 2025 Earnings Call Transcript

Mehr anzeigen
Fulgent Genetics, Inc. (FLGT) Q2 2025 Earnings Call Transcript
BusinessWire

Fulgent Reports Second Quarter 2025 Financial Results

Core Revenue of $81.7 million grows 16% year-over-year Raising Full Year 2025 Core Revenue Guidance to $320 million GAAP gross profit of $34.4 million, or GAAP gross margin of 42.1%; Non-GAAP gross profit of

Mehr anzeigen
Fulgent Reports Second Quarter 2025 Financial Results